Integrating CDK4/6 inhibitors in the treatment of patients with early breast cancer.

Breast · 2022 · PMC9097805 · PMID 34930649

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Patients without previous chemotherapy showed a trend for benefit from palbociclib, but the interaction test was not positive.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.